Integrated Psychiatry for Individuals with Developmental Disabilities

• By: Shawn P. Quigley, PhD, BCBA-D Danielle Block MBA, BSN, RN Frank L. Bird MEd, BCBA, LABA Melmark
• October 1st, 2019
• behavior analysis, developmental disabilities, integrated care, interdisciplinary teams, polypharmacy, psychotropic medication, residential treatment
• 1308    0

Use of psychotropic drugs for individuals with developmental disabilities is common practice. For example, Jobski, Hofer, Hoffman, and Bachmann (2016) documented an overall median use of psychotropic drugs in 45.7% of individuals with autism spectrum disorder (ASD). Wink et al., (2018) documented...